Macquarie to acquire Currenta from Bayer and Lanxess for €3.5bn

German pharma company Bayer and specialty chemicals company Lanxess have signed corresponding agreements with Macquarie Infrastructure and Real Assets (MIRA) to sell their stakes in ... Read More